Michele Maria Luchetti Gentiloni is an expert in Rheumatology at Consultoria Medica e Pesquisa Clinica Cmpc (Brazil). As of October 2026, ScienceLeadR ranks Michele Maria Luchetti Gentiloni in the top 1% of experts in Brazil for Spondylarthritis, Arthritis and Skin Diseases, Papulosquamous. Michele Maria Luchetti Gentiloni has authored 83 publications, the most recent in 2026, and is an investigator in 4 clinical trials. SLR score: 337 (community average: 125). How the SLR is computed.

LeadR Profile

Michele Maria Luchetti Gentiloni Consultoria Medica e Pesquisa Clinica Cmpc Brazil
337 ScienceLeadR Reputation 337
Network Map

Rheumatology

Subspecialties: Immunology - Dermatology - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2000 - 2026

Source: PubMed

Marche Polytechnic University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 83

Citations

Citations: 1 387 1st author: 18 Last author: 4 Unique author: 1


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
IMPACT study: large real-world evaluation of guselkumab in psoriatic arthritis integrating clinical response and treatment persistence.
PMID 42719485 — arthritis, psoriatic, safety, arthritis, therapeutics
Ther Adv Musculoskelet Dis20260
The role of integrated gastro-rheumatological care in IBD-associated Spondyloarthritis in achieving joint-gut remission: Four-year outcomes from the real-world SPIB cohort.
PMID 42276008 — arthritis, rheumatic diseases, therapeutics
Semin Arthritis Rheum20260
Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritis.
PMID 42137340 — safety, therapeutics, retention, psychology, axial spondyloarthritis
Front Pharmacol20260
Frequency and characteristics of axial involvement in psoriatic arthritis: results from the International Multicentre AXIS Study.
PMID 41896130 — arthritis, psoriatic, arthritis, hla-b antigens, spine
Ann Rheum Dis20260
Comparative effectiveness and predictors of remission between adalimumab and ixekizumab in patients with psoriatic arthritis: findings from the 'AIRE' multicentre study.
PMID 41876147 — arthritis, psoriatic, pharmaceutical preparations, arthritis, rheumatic diseases, adalimumab, therapeutics, interleukin-17, functional status
RMD Open20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 4 2
N/A 1
Phase 3 1

By status:

Completed 3
Unknown 1

By type:

Interventional 3
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 0
multicentricup10 2

Main Topics

LeadR Networks

Main global connection map